Abhilasha Khanna & Samudra Sarangi
Latest
NPPA & Overcharging: The MRP v. ASP conundrum
Until not that along ago, drugs and medical devices were distinct from each other and it was this distinction that kept manufacturers of medical devices away the clutches of India's pricing regulator
More Authors You Might Like
-
Sherin Shibu
News Reporter
-
Carl Stoffers
Senior Business Editor
-
Jonathan Herrick
CEO of Benchmark
-
Par Chadha
Founder, CEO, and CIO of HandsOn Global Management
-
Vasily Voropaev
CEO of Smartbrain.io
-
Emily Rella
Senior News Writer
-
Amanda Breen
Senior Features Writer